A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from ...

Galmed Pharmaceuticals Ltd. GLMD shares are trading higher after the company announced the development of a brain penetrating ...

Roche has joined its Big Pharma peers in the emerging degrader-antibody conjugate (DAC) space, paying C4 Therapeutics $20 ...

Barcelona researchers have created an algorithm for studying protein aggregation and mutating proteins from AlphaFold.

Scientists at Oregon State University have captured something researchers have long struggled to see: the real-time chemical interactions that help drive Alzheimer’s disease. By watching how metal ...

AC Immune Announces Amendment to Morphomer® Tau License and Collaboration Agreement with LillyAmended agreement reflects growing excitement in ...

Micro- and nanofluidic systems are increasingly important in biology, medicine, chemistry, and materials science because they allow researchers to study reactions, transport, and molecular behavior in ...

Tafamidis treatment was associated with a significant reduction in the risk of ischemic stroke in patients with ATTR-CM and AF.

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

A team of researchers from NYU Abu Dhabi and the University of Denver has identified a promising small molecule that could ...

Research in microgravity offers unique insights into materials science, improving crystal formation and advancing the ...

Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other related disorders, represent a ...